Project Grant H79TI086830

Award Date 9/30/23
Completion Date 9/29/28
Dollars Obligated $4.5M
Federal Grant Program
93.243
Assistance Type
Project Grant
Place of Performance
Missouri, USA
Similar Awards
This federal Cooperative Agreement award of $1,800,000 from the National Center for HIV/AIDS (CFDA 93.940 - HIV Prevention Activities Health Department Based) will support the Sacramento County Department of Health Services, Division of Public Health in expanding access to HIV/STI prevention, testing, and care services for priority populations in Sacramento County. Key products and services to be delivered include: Expanding the Sexual Health Clinic's clinical infrastructure and service delivery...
The Health Services Kentucky Cabinet For was awarded a $11,263,403 Cooperative Agreement by the National Center for HIV/AIDS (CFDA 93.940 - HIV Prevention Activities Health Department Based) to implement high-impact HIV prevention and surveillance programs across Kentucky over a 5-year period from August 2024 to May 2029. The project will align core HIV prevention, Ending the HIV Epidemic, surveillance, and Ryan White services to achieve goals outlined in the National HIV/AIDS Strategy...
The Kansas Department of Health and Environment (KDHE) was awarded a $846,443 Project Grant under the HIV Care Formula Grants program (CFDA 93.917) by the U.S. Department of Health and Human Services Health Resources and Services Administration. This grant will support KDHE's efforts to improve the quality, availability, and organization of comprehensive HIV/AIDS health care, treatment, and support services for low-income individuals living with HIV in Kansas. The funding will enable KDHE to...
The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $500,000 Project Grant under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program to Erise Williams and Associates, Inc. to implement the "STL MADE: Substance Use Disorder Treatment for Racial/Ethnic Minority Populations at Risk for HIV/AIDS" project. The project aims to increase engagement in care for Black/African American individuals 18...
This Project Grant award of $7,000,000 over four years ($1,750,000 per year) was provided by the U.S. Department of Health and Human Services' Health Resources and Services Administration (HRSA) under the Minority HIV/AIDS Fund (CFDA 93.899) program. The award recipient, JSI Research & Training Institute Inc., is partnering with the National Minority AIDS Council (NMAC) to advance the development, implementation, evaluation, and dissemination of system-level syndemic approaches to reduce...
This $1,199,913 federal Project Grant award from the U.S. Department of Health and Human Services' Minority HIV/AIDS Fund (CFDA 93.899) supports the Mississippi Public Health Institute's (MSPHI) "Helping Empower, Advocate, and Reach the Delta" (HEARD) program. The HEARD program aims to increase engagement in care for adult Black females, including cisgender, transgender, nonbinary, and genderqueer/fluid individuals, who are living with or at high risk for contracting HIV/AIDS, STIs,...
This federal Project Grant award of $1,020,000 was provided by the U.S. Department of Health and Human Services (HHS) under the Minority HIV/AIDS Fund (MHAF) program (CFDA 93.899). The award was granted to Positive Impact Health Centers Inc., a non-profit organization in Atlanta, Georgia, to implement the CASHA: Collaborative Approach to Syndemic Health in Atlanta project. The project aims to improve HIV care and treatment for racial and ethnic minority populations in the Atlanta metropolitan...
The Kansas Department of Health and Environment (KDHE) received a $500,000 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the HIV Prevention Activities Health Department Based (CFDA 93.940) federal grant program. The award, effective September 1, 2024 through August 31, 2027, will fund KDHE's "KANSAS COMMUNITY HEALTH WORKER (CHW) REACH" program. This program aims to implement community health worker-mediated services to re-engage and provide...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), will fund the development of a new collaborative eligibility platform to increase linkage to care and retention in care for over 500,000 people diagnosed with HIV who receive services through the Ryan White HIV/AIDS Program (RWHAP). The $1,243,071 award to Groupware Technologies, LLC will support the creation of a web-based system that streamlines the...
The City of Philadelphia, through its Department of Public Health (PDPH) Division of HIV Health, has been awarded a $18,178,156 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) under the HIV Prevention Activities Non-Governmental Organization Based program (CFDA 93.939). The 5-year grant, beginning August 1, 2024, will support a comprehensive HIV prevention and surveillance program to prevent new HIV infections and improve health outcomes for people with HIV in the...

MINORITY HIV INITIATIVE OF KANSAS CITY: A SYNDEMIC APPROACH - KANSAS CITY CARE CLINIC DBA KC CARE HEALTH CENTER (KC CARE) SEEKS TO EXPAND THE BREADTH AND DEPTH OF OUR HIV SERVICES THROUGH FUNDING FROM SAMHSA'S "MINORITY AIDS INITIATIVE: SUBSTANCE USE DISORDER TREATMENT FOR RACIAL/ETHNIC MINORITY POPULATIONS AT HIGH RISK FOR HIV/AIDS." AS A RYAN WHITE RECIPIENT SINCE 1993, KC CARE POSSESSES BOTH THE EXPERIENCE AND THE INFRASTRUCTURE NECESSARY TO ENSURE SUCCESSFUL STEWARDSHIP OF THE FUNDS REQUESTED. THIS AWARD WILL SUPPORT ON-SITE RAPID HIV AND HEPATITIS C TESTING, CONDUCTED BOTH IN OUR CLINICAL SPACES AND ON A WALK-IN BASIS BY PREVENTION SPECIALISTS. HEPATITIS B TESTING WILL BE AVAILABLE THROUGH OUR CLINIC. AS INJECTION DRUG USE IS A MAJOR CONTRIBUTING FACTOR TO HIV AND VIRAL HEPATITIS, KC CARE WILL FOCUS THIS WORK ON PATIENTS WHO ACCESS OUR HARM REDUCTION SERVICES, PARTICULARLY THOSE WHO IDENTIFY AS BLACK, INDIGENOUS, OR PEOPLE OF COLOR (BIPOC) AND/OR LGBTQ+. KC CARE ALSO CONDUCTS TESTING ON AN OUTREACH BASIS AT NUMEROUS COMMUNITY LOCATIONS, INCLUDING SHELTERS FOR THE UNHOUSED, LONG-TERM STAY HOTELS, PUBLIC LIBRARIES, CHARITABLE NUTRITION ORGANIZATIONS, AND MORE. PEOPLE WHO TEST REACTIVE AT KC CARE, DURING AN OUTREACH EVENT, OR AT ONE OF OUR PARTNER TESTING SITES WILL IMMEDIATELY BE PUT INTO CONTACT WITH A LINKAGE-TO-CARE COORDINATOR. LINKAGE-TO-CARE COORDINATORS ARE AVAILABLE 24/7 AND RESPOND IN REAL TIME TO NEW DIAGNOSES OF HIV AND ENSURE PATIENTS WHO TEST REACTIVE ARE LINKED TO CONFIRMATORY TESTING. WHEN AN HIV DIAGNOSIS IS CONFIRMED, THE LINKAGE-TO-CARE COORDINATOR PROVIDES ALL NECESSARY REFERRALS FOR MEDICAL CARE, CONNECTS THE PATIENT TO A PEER EDUCATOR, AND PROVIDES INTENSIVE CASE MANAGEMENT FOR THE FIRST 90 DAYS AFTER THE PATIENT'S DIAGNOSIS. KC CARE'S LINKAGE-TO-CARE COORDINATORS WORK TO ENSURE PEOPLE NEWLY DIAGNOSED ARE LINKED TO CARE WITHIN 30 DAYS; HOWEVER, KC CARE'S RAPID START PROGRAM ENSURES MANY PEOPLE LEAVE OUR FACILITY WITH ANTIRETROVIRAL MEDICATION THE SAME DAY THEY TEST REACTIVE. THIS EVIDENCE-BASED PRACTICE DRAMATICALLY INCREASES THE LIKELIHOOD THAT PEOPLE WHO ARE NEWLY DIAGNOSED WILL BE ABLE TO ACHIEVE VIRAL SUPPRESSION QUICKLY. ONCE SOMEONE NEWLY DIAGNOSED WITH HIV COMPLETES THEIR FIRST 90 DAYS OF TREATMENT, THEY WILL TRANSITION TO ONE OF KC CARE'S MEDICAL CASE MANAGERS. CASE MANAGERS ARE ASSIGNED TO BEST MEET THE NEEDS OF EACH INDIVIDUAL PATIENT. BOTH LINKAGE-TO-CARE COORDINATORS AND CASE MANAGERS ALSO HELP PATIENTS ACCESS ORAL AND BEHAVIORAL HEALTHCARE THROUGH KC CARE, AND BEHAVIORAL HEALTH CONSULTANTS RESPOND IN REAL TIME TO PATIENTS WITH AND WITHOUT HIV WHO EXHIBIT SIGNS OR DISCLOSE SYMPTOMS DURING MEDICAL AND DENTAL APPOINTMENTS. KC CARE'S THERAPISTS ARE EXPERIENCED AT PROVIDING TREATMENT FOR PATIENTS WHO WISH TO DECREASE OR DISCONTINUE THEIR SUBSTANCE USE, AND WE ARE WORKING TO INCREASE THE AVAILABILITY OF MEDICATION-ASSISTED TREATMENT FOR OPIOID USE DISORDER. THOSE WHO TEST REACTIVE FOR VIRAL HEPATITIS WILL SIMILARLY RECEIVE REFERRALS TO KC CARE'S PRIMARY CARE PROGRAM FOR TREATMENT. KC CARE OPERATES ONE OF THE MOST ROBUST VIRAL HEPATITIS TREATMENT CLINICS IN THE REGION. PATIENTS WHO ATTEND CLINICAL VISITS AT KC CARE AND DO NOT HAVE HIV BUT DISCLOSE BEHAVIORS THAT INCREASE THEIR LIKELIHOOD OF ACQUIRING HIV WILL BE REFERRED TO THE PREP NAVIGATOR. THE PREP NAVIGATOR WILL RESPOND IN REAL TIME WHENEVER POSSIBLE. KC CARE STAFF ARE ALSO KNOWLEDGEABLE ABOUT PEP AND CAN LINK PATIENTS TO MEDICATION QUICKLY THROUGH OUR ON-SITE PHARMACY. THIS STATUS-NEUTRAL APPROACH ENSURES PATIENTS WHO VISIT KC CARE WILL RECEIVE THE KNOWLEDGE AND CARE NECESSARY TO LIVE A HEALTHY AND FULFILLING LIFE, WITH OR WITHOUT HIV. THIS IS CRITICAL TO "ENDING THE HIV EPIDEMIC," A PRIMARY CONCERN OF KC CARE, AS MISSOURI IS LISTED AS ONE OF THE PRIMARY JURISDICTIONS.

Posted 9/18/23, 12:00 AM